Advertisement

drug analysis

drug analysis

  • Rethink your Impurity Analysis Strategy

Rethink your Impurity Analysis Strategy

, , , , |

In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.

  • Targeting Biological Aging: A New Paradigm for 21st Century Medicine

Targeting Biological Aging: A New Paradigm for 21st Century Medicine

, , |

During this webinar, Dr. Matt Kaeberlein provides an overview of translational geroscience, which he believes will become the paradigm for the practice of medicine in the 21st century. He also discusses his recent work with one such intervention, the drug rapamycin, and its potential to enhance healthspan in companion dogs and people.

Go to Top